OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy

Joanna Metzner-Sadurski: Join the OncoDaily Global Oncology Congress 2026

Salah-Eddin Al-Batran: Cancer Is a Race Against Time - We Need to Move Faster

Oncology News, Insights, Stories by OncoDaily

REZILIENT3
Lung Oncology

REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC

Susan G. Komen
Career Updates

Susan G. Komen Names Amber Guild as New President and CEO

Bartłomiej Kubkowski Baltic Sea swim
Celebrities and Cancer

Swim Against Cancer: Bartłomiej Kubkowski’s Historic 160-Km Baltic Crossing

Lacy Hubbard: What Happens After You Screen Nearly Half a Million Women?

Zainab Shinkafi-Bagudu: Nigeria Surpasses 17 Million HPV Vaccinations in Push to Eliminate Cervical Cancer

Herbert Loong: Optimizing Datopotamab Deruxtecan Safety in Advanced NSCLC

Angela Mastronuzzi: Book for Caring for the Child, Not Just the Tumor

5 Messages Shaping GI Oncology After ESMO GI 2026: Highlighted by Maria Maddalena Laterza

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Andrea Necchi: Another Option for 2L Therapy of Advanced Clear Cell RCC?

Voices
Estela Rodriguez

Estela Rodriguez: Targeted Therapies for Lung Cancer in 2026

Felicia Knaul: Closing the Global Gap in Pain and Palliative Care

Naveen Pemmaraju: New Research on NPM1 Mutations in AML

Jason Yongsheng Chan: Strengthening Lymphoma and Sarcoma Care at NCCS

Al-Ola Abdallah: Living Between Two Worlds

Robin Zon: Outstanding Talks at the Denali Oncology Group Meeting

Massimo Cristofanilli: Confirming the Prognostic Value of MRD Detection in Early Triple Negative Breast Cancer

FDA Approvals
Zenbexus

FDA Grants Accelerated Approval to Bristol Myers Squibb’s Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

The Best of Lung Cancer 2026

Innovative Healthcare Institute (IHCI)

03 Oct
Best of Lung Cancer

The 2026 CPTAC Scientific Symposium

National Cancer Institute

21 Sep
CPTAC Scientific Symposium

NCI The Genomic, Host, and Microenvironmental Determinants of Cancer Progression Webinar

National Cancer Institute

19 Aug
Cancer Progression Webinar

The World Radiotherapy Awareness Day - WRAD 2026

World Radiotherapy Awareness Day (WRAD)

07 Sep
World Radiotherapy Awareness Day

The Multidisciplinary GI Oncology Summit 2026

Binaytara

03 Oct
GI Oncology Summit

Immune-oncology
CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

CheckMate 77T study: Can ctDNA Predict Response to Perioperative Immunotherapy in NSCLC?

PIVOTAL Trial: Neoadjuvant Intralesional Immunotherapy in Melanoma

Hypoxia and Immunotherapy Resistance: Can HIF Targeting Improve Response?

In Vivo CAR-T Cell Therapy: Clinical Proof of Concept and the Rising Role of AI

Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Can Diet and the Gut Microbiome Improve Immunotherapy Response?

Gastrointestinal-Oncology
ESMO GI - Maria Maddalena Laterza

5 Messages Shaping GI Oncology After ESMO GI 2026: Highlighted by Maria Maddalena Laterza

CAVE and CAVE-2 GOIM Studies: Predictive biomarkers for Cetuximab-Based Rechallenge in mCRC

NETTER-2: First-Line [177Lu]Lu-DOTA-TATE plus Octreotide in Advanced G2-G3 GEP-NETs

Daraxonrasib Resistance in Pancreatic Cancer Points to New Combination Strategies

Five-Year CheckMate 648 Follow-Up: Nivolumab-Based Therapy in Advanced ESCC

Liver Transplantation After Chemotherapy and SIRT in Unresectable iCCA

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
Tissue-Free ctDNA

Tissue-Free ctDNA Detects MRD Before TNBC Recurrence

Rare Triple-Negative Breast Cancer Is Not One Disease

Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy

Rb-Driven Transcription Reveals a CDK4/6 Paradox in Breast Cancer

ctDNA in Early Breast Cancer: Powerful Promise, Key Gaps

Germline BRCA1 Variants May Impair T Cell Function in Breast Cancer

Radiotherapy in Breast Cancer LMD: Critical Survival Uncertainty

Lung-Oncology
REZILIENT3

REZILIENT3 Trial: Major Positive Phase 3 Result in Exon 20 NSCLC

SYS6010 Shows Encouraging Activity Across Pretreated NSCLC

Rilvegostomig NSCLC: 5 Major Promising Findings From ARTEMIDE-01

Air Pollution and Lung Cancer: Critical Metabolic Clues

Transformed SCLC in EGFR-Mutant NSCLC: Critical Progress in a High-Risk Setting

TP53-Mutated EGFR NSCLC: Powerful PFS Gain With Combination Therapy

Targeted Therapy Resistance in NSCLC: Critical Next Steps

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
JAK, BET inhibitors MANIFEST trial

Novel Combinations in Myelofibrosis: Advancing Beyond the JAK Inhibitor Backbone

FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR

Artificial Intelligence and Digital Pathology in Leukemia Diagnosis

Treatment-Free Remission (TFR) in CML: Who, When, and How?

The Next Frontier in R/R ALL: CAR-T, Bispecifics, and Emerging Strategies

Hematologic Malignancies: Therapeutic Success Amid Epidemiological Failure

Hairy Cell Leukemia (HCL): A Rare Leukemia Treated Well, but Rarely Eradicated

Radiotherapy
TREASURE

TREASURE Trial Raises Safety Concerns Over Thoracic Radiotherapy in ES-SCLC

ESTRO Breast Radiotherapy Target Volumes Prospectively Validated in DBCG Skagen Trial 1

10 Must-Read Posts In Radiotherapy This Week: August 2 -9

DBCG Skagen Trial 1 Validates ESTRO Target Volume Guidelines in Early Breast Cancer

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

OncoDaily TV
Petra Jankowska

Leading with Humanity in Modern Oncology: Dr. Petra Jankowska

Princess Dina

Episode 18: Global Health Dialogues with Princess Dina and Dr Urvi Shah

Empowering Oncologist

Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll

Dr. C.S. Pramesh

The Power of Collaboration in Fighting Cancer: Dr. C.S. Pramesh

Tommy Bramley

Making Innovative Oncology Therapies Accessable for All Patients: Tommy Bramley

Rolando Camacho

Beyond the Policy Paper: Turning Cancer Plans into Real Impact: Dr. Rolando Camacho

Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Not To Miss
Cancer Planners Forum 2026

Cancer Planners Forum 2026: Strengthening National Cancer Control Plans Worldwide

10 Major Cancer Research Grants Offering $1M+

The 7th Emirates Oncology Society Annual Conference 2026

ACS National Lung Cancer Roundtable Sets Priorities for Advanced Imaging in Lung Cancer

Top 10 OncoGrants This Week: Major Funding Opportunities Across Cancer Research

ACS CAN Warns New U.S. Vaccine Order Could Put Cancer Patients and Survivors at Risk

LeukO 2026 to Unite the Global Leukemia Community This September

OncoGrants
Geoffrey Ogram Memorial Research Grant

Lung Cancer Canada Geoffrey Ogram Memorial Research Grant 2026

Cancer Research Collaboration Fellowship

EACR–Worldwide Cancer Research Collaboration Fellowship 2026

Translational Cancer Researcher Award

Pezcoller Foundation–EACR Translational Cancer Researcher Award 2027

Women in Cancer Research Award

Pezcoller–Marina Larcher Fogazzaro–EACR Women in Cancer Research Award 2027

Research Fellowship

Arthur Child Cancer Centre Lung Cancer Clinical and Research Fellowship

Clinical Research Mentorship

The Clinical Research Mentorship Program - CRMP 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Eric Van Cutsem

Eric Van Cutsem

Oncologists Location Leuven, Belgium
Cathy Eng

Cathy Eng

Oncologists Location Nashville, USA
Soumita Majumdar

Soumita Majumdar

Oncologists Location Kolkata, India
Edoardo Francini

Edoardo Francini

Oncologists Location Florence, Italy
Charbel Matar

Charbel Matar

Oncologists Location Washington, USA
Mary Gospodarowicz

Mary Gospodarowicz

Oncologists Location Toronto, Canada
Yasmine Yasser Hassaneen

Yasmine Yasser Hassaneen

Oncologists Location Cairo, Egypt
Imène Hadji

Imène Hadji

Oncologists Location Guelma, Algeria

Oncology Drugs
OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

OTX-2002: Innovative MYC-Targeting mRNA Therapy, Dose, Administration, and Clinical Trials

mRNA-4359: Promising Cancer Vaccine, Dose, Administration, and Clinical Trials

BXCL701: Promising Innate Immune Activation, Dose, Administration, And Clinical Trials

NBTXR3: Promising Radioenhancer, Administration, Dose, And Clinical Trials

KT-333: Promising STAT3 Degradation, Dose, Administration, And Clinical Trials

Veliparib: Mechanism, Dose, Administration, And Clinical Trials

Adavosertib: Mechanism, Dose, Administration, And Clinical Trials

OncoDaily Magazine

New Paper Alert
Gary Lyman

Gary Lyman: Unlocking Cancer Insights Through ctDNA

Muzaffar Qazilbash

Muzaffar Qazilbash: CAR-T and Bispecific Antibodies in Multiple Myeloma

Julia Carnevale

Julia Carnevale: Targeting P2RY8 and GNAS to Enhance T Cell Therapy in Solid Tumors

Raffaele Colombo

Raffaele Colombo: New Insights Into ADC Linker Stability and Clinical Translation

Sanam Loghavi

Suggested Articles on Leukemia and Hematopathology Shared by Sanam Loghavi

Anas Younes

Anas Younes: Decade-Long Persistence of CD19 CAR T Cells in B Cell Lymphomas

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries